ENTITY

Sierra Oncology (SRRA US)

Analysis

Health Care • United States

Sierra Oncology, Inc. operates as a clinical-stage oncology company. The Company develops therapies that target deoxyribonucleic acid (DNA) to treat patients with cancers and other complex genetic diseases. Sierra Oncology serves customers in North America.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00